# Tolerance Study of Allogeneic of Adipose Tissue Derived Mesenchymal Stroma/Stem Cells (AdMSC) Transplantation in Patients With Critical Limb Ischemia.

> **NCT06795620** · PHASE1 · NOT_YET_RECRUITING · sponsor: **University Hospital, Toulouse** · enrollment: 10 (estimated)

## Conditions studied

- Critical Limb Ischemia

## Interventions

- **DRUG:** Adipose tissue derived mesenchymal Stroma/stem Cells transplantation

## Key facts

- **NCT ID:** NCT06795620
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01
- **Primary completion:** 2028-01
- **Final completion:** 2028-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06795620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06795620, "Tolerance Study of Allogeneic of Adipose Tissue Derived Mesenchymal Stroma/Stem Cells (AdMSC) Transplantation in Patients With Critical Limb Ischemia.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06795620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*